Edition:
India

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

91.05USD
1:30am IST
Change (% chg)

$0.31 (+0.34%)
Prev Close
$90.74
Open
$90.70
Day's High
$91.50
Day's Low
$90.64
Volume
1,249,789
Avg. Vol
1,361,544
52-wk High
$91.50
52-wk Low
$76.42

Latest Key Developments (Source: Significant Developments)

Medtronic Receives FDA Approval For Implantable System For Remodulin To Treat Patients With Pulmonary Arterial Hypertension
Tuesday, 31 Jul 2018 

July 31 (Reuters) - Medtronic PLC ::MEDTRONIC RECEIVES FDA APPROVAL FOR IMPLANTABLE SYSTEM FOR REMODULIN® TO TREAT PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION.MEDTRONIC PLC - MEDTRONIC SYNCHROMED(TM) II PUMP, PROPRIETARY CATHETER DELIVER UNITED THERAPEUTICS' REMODULIN® (TREPROSTINIL) INJECTION.  Full Article

United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®
Tuesday, 31 Jul 2018 

July 31 (Reuters) - United Therapeutics Corp ::UNITED THERAPEUTICS ANNOUNCES FDA APPROVAL OF THE IMPLANTABLE SYSTEM FOR REMODULIN®.UNITED THERAPEUTICS - APPROVAL OF NDA FOR USE OF REMODULIN INJECTION IN IMPLANTABLE SYSTEM FOR REMODULIN.  Full Article

Medtronic Wins Expanded Indication For Selectsecure MRI Surescan Pacing Lead For His Bundle Site Stimulation
Thursday, 12 Jul 2018 

July 12 (Reuters) - Medtronic PLC ::MEDTRONIC WINS EXPANDED INDICATION FOR SELECTSECURE MRI SURESCAN PACING LEAD FOR HIS BUNDLE SITE STIMULATION.FDA LABELING EXPANSION FOR MEDTRONIC SELECTSECURE MRI SURESCAN MODEL 3830 CARDIAC PACING LEAD TO INCLUDE STIMULATION OF BUNDLE OF HIS.  Full Article

Medtronic Increases Quarterly Cash Dividend By 9 Pct
Friday, 22 Jun 2018 

June 22 (Reuters) - Medtronic PLC ::REG-MEDTRONIC ANNOUNCES 9 PERCENT INCREASE IN CASH DIVIDEND.INCREASES QUARTERLY CASH DIVIDEND BY 9 PERCENT TO $0.50PER SHARE.  Full Article

FDA Classifies HeartWare Systems Unexpected Power Source Switching As Class I Recall
Saturday, 2 Jun 2018 

June 1 (Reuters) - Medtronic PLC ::FDA CLASSIFIES HEARTWARE SYSTEMS UNEXPECTED POWER SOURCE SWITCHING AS CLASS I RECALL.MEDTRONIC PLC - THERE HAVE BEEN NO CONFIRMED REPORTS OF "CATASTROPHIC HARM" ASSOCIATED WITH ISSUE.MEDTRONIC PLC - RECALL AFFECTS 16,399 HEARTWARE VENTRICULAR ASSIST DEVICE SYSTEMS IMPLANTED AS OF MAY 22, 2018.MEDTRONIC - CLASSIFIED MEDTRONIC'S VOLUNTARY URGENT FIELD ACTION RELATED TO HEARTWARE HVAD SYSTEM UNEXPECTED POWER SOURCE SWITCHING AS CLASS I RECALL.  Full Article

Medtronic Announces FDA Approval Of Infuse Bone Graft In New Spine Surgery Indications
Monday, 30 Apr 2018 

April 30 (Reuters) - Medtronic PLC ::MEDTRONIC ANNOUNCES FDA APPROVAL OF INFUSE(TM) BONE GRAFT IN NEW SPINE SURGERY INDICATIONS USING PEEK INTERBODY IMPLANTS.  Full Article

Medtronic In.Pact Admiral Drug Coated Balloon Receives FDA Approval
Monday, 23 Apr 2018 

April 23 (Reuters) - Medtronic PLC ::MEDTRONIC IN.PACT(TM) ADMIRAL(TM) DRUG COATED BALLOON RECEIVES FDA APPROVAL TO TREAT LONG SFA LESIONS.MEDTRONIC PLC - APPROVAL WAS BASED ON CLINICAL DATA FROM COMPLEX LESION IMAGING COHORTS OF IN.PACT GLOBAL STUDY.  Full Article

Medtronic Announces U.S. Launch Of Optisphere Embolization Spheres
Tuesday, 17 Apr 2018 

April 17 (Reuters) - Medtronic PLC ::MEDTRONIC - ANNOUNCES U.S. LAUNCH OF OPTISPHERE EMBOLIZATION SPHERES, A RESORBABLE EMBOLIC PLATFORM DESIGNED FOR EMBOLIZATION OF HYPERVASCULAR TUMORS.  Full Article

Medtronic Gets FDA Approval For Guardian Connect CGM System For People With Diabetes
Monday, 12 Mar 2018 

March 12 (Reuters) - Medtronic Plc ::MEDTRONIC RECEIVES FDA APPROVAL FOR GUARDIAN CONNECT CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM FOR PEOPLE LIVING WITH DIABETES.SAYS ‍GUARDIAN CONNECT SYSTEM WILL BE AVAILABLE IN Q1 OF CO'S FISCAL YEAR 2019​.  Full Article

Medtronic PLC Says ‍Approved Fiscal Year 2018 Q4 Cash Dividend Of $0.46/Ordinary Share
Friday, 9 Mar 2018 

March 9 (Reuters) - Medtronic Plc ::MEDTRONIC PLC - ‍APPROVED FISCAL YEAR 2018 Q4 CASH DIVIDEND OF $0.46/ORDINARY SHARE, REPRESENTING 7% INCREASE OVER PRIOR YEAR​.  Full Article

Photo

Israel grants $33 million to GE, Medtronic, Change Healthcare to boost R&D

JERUSALEM Three multinational companies have received an Israeli government grant of 120 million shekels ($33 million) aimed at boosting the presence of large companies and establishing Israel as a hub in biotechnology and medicine.